These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 51654)

  • 41. Early changes in concanavalin A-stimulated lymphocytes detected by the fluorescent probe N-phenyl-1-naphthylamine.
    Rolland JM; Betts RL; Halliday GM; Hocking GR; Nairn RC
    Cell Tissue Res; 1981; 214(1):119-28. PubMed ID: 6970621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-phenyl-1-naphthylamine/β-cyclodextrin inclusion complex as a new fluorescent probe for rapid and visual detection of Pd(2+).
    Maniyazagan M; Mohandoss S; Sivakumar K; Stalin T
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Dec; 133():73-9. PubMed ID: 24929318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perturbation of protein tertiary structure in frozen solutions revealed by 1-anilino-8-naphthalene sulfonate fluorescence.
    Gabellieri E; Strambini GB
    Biophys J; 2003 Nov; 85(5):3214-20. PubMed ID: 14581221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
    Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The determinants of the changes in fluorescence of 8-anilino-1-naphthalene sulfonic acid induced in particle systems.
    Green DE; Vande Zande H
    Biochem Biophys Res Commun; 1982 Aug; 107(4):1300-7. PubMed ID: 7138538
    [No Abstract]   [Full Text] [Related]  

  • 46. Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
    Ruggiero M; Lapetina EG
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3456-9. PubMed ID: 3458190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of phospholipase D in human platelets by collagen and thrombin and its relationship to platelet aggregation.
    Chiang TM
    Biochim Biophys Acta; 1994 Oct; 1224(1):147-55. PubMed ID: 7948037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of 1-anilinonaphthalene-8-sulfonic acid to type I collagen.
    del Pozo AM; Olmo N; Oñaderra M; Lizarbe MA; Gavilanes JG
    Int J Pept Protein Res; 1986 Aug; 28(2):173-8. PubMed ID: 3771101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin.
    Kumar MS; Girish KS; Vishwanath BS; Kemparaju K
    Ann Hematol; 2011 May; 90(5):569-77. PubMed ID: 20957364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of collagen-induced platelet aggregation by argatroban in patients with acute cerebral infarction.
    Imiya M; Matsuo T
    Thromb Res; 1997 Oct; 88(2):245-50. PubMed ID: 9361377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of platelet fibronectin immunofluorescence in peripheral vascular disease and diabetes mellitus.
    Ejim OS; Barradas MA; Mikhailidis DP; Poulter LW; Coumar A; Dandona P
    Microcirc Endothelium Lymphatics; 1989 Dec; 5(6):373-90. PubMed ID: 2483853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
    Puri RN; Kumar A; Chen H; Colman RF; Colman RW
    J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H; McGregor JL
    Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of conformational changes in immunoglobulin G using isothermal titration calorimetry with low-molecular-weight probes.
    Rispens T; Lakemond CM; Derksen NI; Aalberse RC
    Anal Biochem; 2008 Sep; 380(2):303-9. PubMed ID: 18577365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction.
    Liu CZ; Huang TF
    Arch Biochem Biophys; 1997 Jan; 337(2):291-9. PubMed ID: 9016825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
    Puri RN; Colman RW
    Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Release of a fluorescent probe as an indicator of lysosomal granule secretion by thrombin-stimulated human platelets.
    Greenberg-Sepersky SM; Simons ER
    Anal Biochem; 1985 May; 147(1):57-62. PubMed ID: 4025824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition and potentiation of platelet function by lysolecithin.
    Joist JH; Dolezel G; Cucuianu MP; Nishizawa EE; Mustard JF
    Blood; 1977 Jan; 49(1):101-12. PubMed ID: 830368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.
    Suba EA; Csako G
    J Immunol; 1976 Jul; 117(1):304-9. PubMed ID: 1084367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.